Recently, our company successfully participated in the 76th American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo (ADLM2024), held in Chicago, USA, from July 28 to August 1, 2024, at the McCormick Place Convention Center. This prestigious event attracted over 20,000 professionals from 110 countries worldwide, marking it as a significant milestone in the global clinical laboratory industry.

During the exhibition, our company's booth stood out for its cutting-edge medical technology products and dedicated service team. Our representatives enthusiastically showcased our latest innovations, including advanced in vitro diagnostic instruments, reagents, and tumor genetic testing technologies. In particular, our self-developed intestinal tumor genetic testing technology, automated detection systems, and HemoPOC? coagulation testing system garnered significant attention.

The booth not only demonstrated our company's latest achievements in medical technology but also allowed attendees to experience firsthand the superior performance and ease of operation of our products through live demonstrations and interactive sessions. Furthermore, our team engaged in profound discussions with experts from the global medical industry, sharing the latest research findings and technological advancements while exploring future trends and challenges in medical technology.

This participation has not only showcased our company's innovative prowess but also strengthened our existing partnerships and opened up new markets. During the exhibition, we established connections with potential clients from Panama, Argentina, Uruguay, and other countries, laying a solid foundation for future international collaborations.

ADLM2024, as a top-tier event in the global clinical laboratory field, provided an exceptional platform for our company to display our innovative achievements and expand our international presence. Committed to the principles of "Innovation, Excellence, and Mutual Success," we will continue to drive the development of medical technology and contribute more to the global health industry.